Four weeks of Ledipasvir/Sofosbuvir plus Ribavirin with or without interferon gives very high and sustained cure rates in difficult to reach but easy to treat injecting drug users with chronic hepatitis C: final results of the 4WIDUC study: Journal of Hepatology

A L H Øvrehus, H. Krarup, Inge Birkemose, B. Mössner, P. B. Christensen

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberTHU-225
JournalJournal of Hepatology
Volume66
Issue number1
Pages (from-to)S287-S287
ISSN0168-8278
DOIs
Publication statusPublished - 2017
Event The International Liver Congress / 52nd Annual meeting of the European Association for the Study of the Liver - Amsterdam, Netherlands
Duration: 19 Apr 201723 Apr 2017

Conference

Conference The International Liver Congress / 52nd Annual meeting of the European Association for the Study of the Liver
Country/TerritoryNetherlands
CityAmsterdam
Period19/04/201723/04/2017

Keywords

  • Gastroenterology & Hepatology

Cite this